Macclesfield, United Kingdom

Nelly Corine Moore


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Nelly Corine Moore from Macclesfield, GB

Introduction: Nelly Corine Moore is an accomplished inventor based in Macclesfield, Great Britain. With a keen focus on innovation in the pharmaceutical field, she has successfully secured three patents that demonstrate her contributions to medical science.

Latest Patents: Among her notable inventions are quinazoline compounds, which have shown therapeutic uses. Her recent patents include:

1. **Quinazoline compounds with therapeutic use** - This invention pertains to the use of quinazoline derivatives of Formula (I) for the manufacture of a medicament aimed at preventing or treating T cell mediated diseases or medical conditions in warm-blooded animals.

2. **Quinazoline derivatives for the treatment of T cell mediated diseases** - This patent concerns the same class of quinazoline derivatives, focusing on their application in developing medications for similar medical conditions.

Career Highlights: Nelly is currently employed by AstraZeneca AB, a leading global biopharmaceutical company. Her work here emphasizes the development of innovative treatments that can address significant health challenges.

Collaborations: Throughout her career, Nelly has had the opportunity to collaborate with her esteemed coworker, Keith Oldham. Their partnership has fostered an environment of creativity and problem-solving, leading to significant advancements in their field.

Conclusion: Nelly Corine Moore's innovative spirit and dedication to research exemplify the impact that a single inventor can have on the world of medicine. Her work in developing quinazoline compounds is a testament to the ongoing fight against diseases and the vital role of invention in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…